The Food and Drug Administration recently issued its first-ever approval of an artificial pancreas that may make life easier and healthier for such patients. The device, made by Minneapolis-based Medtronics, relies on a computer algorithm to sync the results of a continuous reading of the wearer's glucose levels and with a pump that provides appropriate amounts of insulin.